Abano forecasts FY loss of $1.3M-$1.9M on sale of Aotea stake, Orthotics

Thu, 23 Apr 2015

By Jonathan Underhill April 24 (BusinessDesk) - Abano Healthcare expects to report a small full-year loss after the specialist medical investment firm agreed to sell its stake in Aotea Pathology and following the sale of its orthotics unit in January, which resulted in impairments on both businesses. The net loss is expected to be $1.3 million to $1.9 million in the year ending May 31, the Auckland-based company said in a statement. Excluding impairments and loss on sale, annual profit is forecast at $7.2 million to $7.8 million, up from...

Try free for 10 days

Trustworthy, balanced journalism every day from our growing team of New Zealand business reporters and commentators, plus more in our weekend magazine section, The Life.

Instant News Alerts based on keywords you choose or journalists you follow
Our Daily Digest of all stories at 6am, midday or 6pm
A custom library of your saved stories
An industry-leading search engine
Try for 10 days without paying and if you’re not convinced cancel with just two clicks.

Support quality New Zealand journalism by subscribing today.

Find out more

Not convinced yet?

Subscribe to our Daily News Update free newsletter.

Listed Companies

DAN BRUNSKILL: Serko has nothing but time

Dan Brunskill | Tue, 22 Sep 2020

How does a travel software firm crack the top 50 stocks when international borders are closed?

Property

JENNY RUTH: Aged-care sector in danger of valuer capture

Jenny Ruth | Tue, 22 Sep 2020

CBRE director Michael Gunn and his team of valuers have built a formidable reputation within the retirement village and aged care sector.

Markets

MARKET CLOSE: Profit taking pulls shares down

Dan Brunskill | Mon, 21 Sep 2020

Profit taking pushed New Zealand’s benchmark stock index more than 500 points below its record as investors found few reasons to buy with a global recession in progress. The S&P/NZX 50 Index fell 94.42 points, or 0.8 percent, to 11,539.10. Within the index, 34 stocks fell, 11...

Partner Content

The whole story behind good investment decisions

If there was ever a time when strong financial metrics were the single trademark of a good company, that time has long passed. Responsible investors need to know beyond the profit a company will generate this year or next.